PanGIA Biotech to Expand Multi-Cancer Early Detection Liquid Biopsy Study
PanGIA Biotech is preparing to launch new clinical studies in multi-cancer early detection using the PanGIA Liquid Biopsy Platform.
Read More
Search Results for: liver disease
NIH Deploys Picodya’s IVD Platform to Detect Global Viral Threats
Picodya, the creator of a hybrid IVD solution for multiplexed POC testing, announced the deployment of its B-Matrix technology in NIH labs.
Read More
New ChromaCode Collaboration to Improve NSCLC Biomarker Testing Access
ChromaCode will collaborate with Tennessee Oncology to test the performance of ChromaCode’s HDPCR NSCLC biomarker assay.
Read More
FDA Clears Qvin Test that Uses Menstrual Blood
The clearance makes it possible for women who live with diabetes to receive monitoring of A1c, using laboratory tests performed on the Q-Pad.
Read More
New Sensor Technology May Enable Early Lung Cancer Detection
The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.
Read More